highperformr logo

Guerbet's Overview

Total employees2510
HeadquartersVillepinte
Founded1926

Guerbet is a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. For nearly a century, Guerbet has been committed to innovation and improving patient outcomes by providing healthcare professionals with advanced tools for diagnosing and treating a wide range of conditions. Their portfolio includes contrast agents for X-ray, MRI, and ultrasound, along with injectors, catheters, guidewires, and digital solutions designed to enhance imaging procedures and clinical decision-making.

Where is Guerbet's Headquarters?

HQ Function

Serves as the central hub for Guerbet's global strategy, corporate governance, research and development leadership, and overall management of its worldwide operations in diagnostic and interventional imaging.

Notable Features:

A modern facility designed to foster innovation and collaboration, likely equipped with advanced research laboratories and administrative offices supporting its global functions. Specific architectural details are proprietary.

Work Culture:

The work culture at Guerbet's headquarters is likely characterized by a strong emphasis on scientific excellence, innovation in medical technology, a commitment to patient well-being, and a collaborative, international environment driven by its global presence.

HQ Significance:

The Villepinte headquarters is significant as it represents the nerve center of Guerbet's nearly century-long dedication to advancing medical imaging, coordinating its efforts to improve diagnostic accuracy and treatment outcomes worldwide.

Values Reflected in HQ: The headquarters likely embodies Guerbet's core values such as innovation, quality, commitment to healthcare, scientific rigor, and fostering a global team spirit.

Location:

Guerbet operates globally, with a strong presence in Europe, North America, Latin America, Asia-Pacific, and the Middle East/Africa. This worldwide network supports sales and marketing, research and development collaborations, manufacturing (in France, USA, Brazil, Ireland), and distribution of its comprehensive portfolio of contrast media, medical devices (injectors, catheters, guidewires), and digital solutions for diagnostic and interventional imaging.

Street Address:

BP 57400, 15 rue des Vanesses

City:

Villepinte

State/Province:

Île-de-France (Seine-Saint-Denis department)

Country:

France

Guerbet's Global Presence

Princeton, New Jersey, USA

Address: Guerbet LLC, 111 Carnegie Center, Suite 200, Princeton, NJ 08540, USA

Key hub for managing commercial activities and customer relations within the significant US healthcare sector.

Tokyo, Japan

Address: Guerbet Japan K.K., Kurosaki Bldg 7F, 4-1-4 Akasaka, Minato-ku, Tokyo 107-0052, Japan

Strategic office for serving the advanced Japanese medical imaging market and expanding Guerbet's presence in the Asia-Pacific region.

Sulzbach (Taunus), Germany

Address: Guerbet GmbH, Otto-Volger-Str. 11, 65843 Sulzbach (Taunus), Germany

Critical for engaging with German healthcare providers and strengthening Guerbet's market share in Central Europe.

Buying Intent Signals for Guerbet

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Guerbet

As of April 2025, Guerbet' leadership includes:

David Hale - Chief Executive Officer
Jérôme Estampes - Chief Financial Officer
Sarah Dayre - Chief Scientific Officer and R&D
Jean-François Le Martret - Chief Digital Officer and Group CIO
Anne-Laure Sanguinetti - VP Global Sales & Marketing Diagnostic Imaging
Philippe Bourrinet - VP Interventional Imaging

Investors of Guerbet

Guerbet has been backed by several prominent investors over the years, including:

Guerbet Family (Concert Action)
Publicly traded on Euronext Paris (Ticker: GBT)

Executive New Hires/Exits in the Last 12 Months

Hire4
Exits1

Guerbet has made several key executive appointments in the past year (May 2023 - May 2024), strengthening its leadership in Finance, Interventional Imaging, Human Resources, and Digital & IT. There was also a notable departure in operations leadership.

Departures

Petra Zalabak, Petra Zalabak departed from her role as Chief Operating Officer to pursue new opportunities.

New Appointments:

Jérôme Estampes, Jérôme Estampes appointed as new Chief Financial Officer, bringing extensive financial expertise.
Philippe Bourrinet, Philippe Bourrinet appointed as new VP Interventional Imaging to drive growth in this key sector.
Jean-François Le Martret, Jean-François Le Martret appointed to lead Guerbet's digital transformation and IT strategy.
Christine Allard, Christine Allard appointed to lead global human resources and talent development.

Technology (Tech Stack) used by Guerbet

Discover the tools Guerbet uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Guerbet Email Formats and Examples

Guerbet commonly utilizes the email format '[first].[last]@guerbet.com' for its employees. While other formats might exist in specific contexts, this is the most frequently observed structure for professional communication.

[first].[last]@guerbet.com

Format

firstname.lastname@guerbet.com

Example

85%

Success rate

News and media

Guerbet Press ReleaseApril 24, 2024

Guerbet Reports Q1 2024 Revenue Growth Driven by Elucirem™ and Optiray®

Guerbet announced its first-quarter 2024 revenue of €188.5 million, up 6.7% at constant exchange rates and 6.0% on a reported basis. This growth was primarily driven by strong sales of Elucirem™ (Gadopiclenol) in the United States and continued robust performance of Optiray®....more

Guerbet Press ReleaseDecember 12, 2023

Guerbet and Bracco Imaging Announce Collaboration for Gadopiclenol in the US

Guerbet and Bracco Imaging entered into a collaboration agreement for the manufacturing and commercialization of Gadopiclenol in the United States. Guerbet will commercialize Elucirem™ and Bracco will commercialize VUEWAY™, both innovative macrocyclic gadolinium-based contrast agents containing Gadopiclenol....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Guerbet, are just a search away.